Literature DB >> 16002050

Transport of dietary phenethyl isothiocyanate is mediated by multidrug resistance protein 2 but not P-glycoprotein.

Yan Ji1, Marilyn E Morris.   

Abstract

We demonstrated recently that phenethyl isothiocyanate (PEITC), a potent anticarcinogen present in cruciferous vegetables, inhibited P-glycoprotein (P-gp) and multidrug resistance protein 1 (MRP1) and that MRP1 can transport PEITC and/or its metabolites. In this study, we have examined whether PEITC is transported by P-gp and MRP2, two transporters with high expression in human intestine, liver and kidney. Using (14)C-PEITC, no significant difference was observed for the intracellular accumulation of PEITC in human breast cancer MCF-7/sensitive (control) and MCF-7/ADR (P-gp overexpressing) cells at PEITC concentrations of 1, 10 and 50 microM. Moreover, the presence of verapamil or PSC833, two P-gp inhibitors, had no significant effect on the intracellular accumulation of PEITC in P-gp overexpressing MCF-7/ADR and MDA435/LCC6MDR1 cells, indicating that PEITC may not be a substrate for P-gp. In contrast, (14)C-PEITC intracellular accumulation in the kidney epithelial MDCK II/MRP2 cells (transfected with human MRP2) was significantly lower than in the wild-type MDCK II/wt cells at PEITC concentrations of 1, 5, 10 and 50 microM. The presence of MK571, an MRP inhibitor, significantly enhanced (14)C-PEITC accumulation in MDCK II/MRP2 but not MDCK II/wt cells. Furthermore, depletion of intracellular glutathione (GSH) following treatment with buthionine sulphoximine, an inhibitor of GSH biosynthesis, significantly increased (14)C-PEITC intracellular accumulation in a concentration-dependent manner. Transcellular transport studies also demonstrated that depletion of intracellular GSH reduced the mean ratio of basal-to-apical transport to apical-to-basal transport of PEITC in MDCK II/MRP2, but not MDCK II/wt cell monolayers. These results indicate that GSH plays an important role in the MRP2-mediated transport of PEITC. The findings provide new information concerning the interactions between PEITC and membrane transporters and suggest the possibility of PEITC interactions with xenobiotics that are MRP2 substrates.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16002050     DOI: 10.1016/j.bcp.2005.05.025

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  5 in total

1.  AM841, a covalent cannabinoid ligand, powerfully slows gastrointestinal motility in normal and stressed mice in a peripherally restricted manner.

Authors:  C M Keenan; M A Storr; G A Thakur; J T Wood; J Wager-Miller; A Straiker; M R Eno; S P Nikas; M Bashashati; H Hu; K Mackie; A Makriyannis; K A Sharkey
Journal:  Br J Pharmacol       Date:  2015-02-27       Impact factor: 8.739

2.  MRP transporters as membrane machinery in the bradykinin-inducible export of ATP.

Authors:  Yumei Zhao; Keisuke Migita; Jing Sun; Takeshi Katsuragi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-02-05       Impact factor: 3.000

3.  ABC transporters and isothiocyanates: potential for pharmacokinetic diet-drug interactions.

Authors:  Urvi Telang; Yan Ji; Marilyn E Morris
Journal:  Biopharm Drug Dispos       Date:  2009-10       Impact factor: 1.627

4.  MiR-135a and MRP1 play pivotal roles in the selective lethality of phenethyl isothiocyanate to malignant glioma cells.

Authors:  Taolan Zhang; Yingying Shao; Tang-Yuan Chu; Hsuan-Shun Huang; Yu-Ligh Liou; Qing Li; Honghao Zhou
Journal:  Am J Cancer Res       Date:  2016-05-01       Impact factor: 6.166

Review 5.  Pharmacokinetics and pharmacodynamics of phenethyl isothiocyanate: implications in breast cancer prevention.

Authors:  Marilyn E Morris; Rutwij A Dave
Journal:  AAPS J       Date:  2014-05-13       Impact factor: 4.009

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.